Onxeo
Onxeo is biotechnology company that develops of drugs for oncology. The company was formed after a 2014 merger of BioAlliance Pharma, a French biotechnology company, and TopoTarget, a Danish biotechnology company.[1]
History and product pipeline
See TopoTarget
References
- ↑ "BioAlliance to Merge With Topotarget in All-Stock Deal". Bloomberg L.P. Retrieved 30 October 2014.
External links
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.